FDA Adverse Event Injury Summary report: N

COREVALVE TRANSCATHETER AORTIC VALVE

MDR report key: 7027323 · Received November 14, 2017

Report

Report Number
2025587-2017-02105
Event Type
Injury
Date Received
November 14, 2017
Date of Event
May 1, 2015
Report Date
November 14, 2017
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

CITATION: FRERKER C. EXPANSION OF THE INDICATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION--FEASIBILITY AND OUTCOME IN "OFF-LABEL" PATIENTS COMPARED WITH "ON-LABEL" PATIENTS. J INVASIVE CARDIOL. MAY 2015; 27(5):229-36 EARLIEST DATE OF PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT COULD NOT BE DETERMINED WHETHER THESE OBSERVATIONS HAVE BEEN PREVIOUSLY REPORTED. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REGARDING OUTCOMES OF PERFORMING TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI). ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 2008 AND 2012. THE STUDY POPULATION INCLUDED 591 PATIENTS (PREDOMINANTLY FEMALE; MEAN AGE 80 YEARS), 343 OF WHICH WERE IMPLANTED WITH MEDTRONIC COREVALVE (SERIAL NUMBERS NOT PROVIDED). AMONG ALL PATIENTS ADVERSE EVENTS INCLUDED: VALVE EMBOLIZATION, MODERATE AORTIC REGURGITATION, PARAVALVULAR LEAK (PVL), VALVE-IN-VALVE, PERMANENT PACEMAKER IMPLANT, STROKE, CARDIOPULMONARY BYPASS (CPB), AND VASCULAR COMPLICATIONS. MULTIPLE MANUFACTURERS WERE NOTED IN THE LITERATURE; BASED ON THE AVAILABLE INFORMATION A DIRECT CORRELATION COULD NOT BE MADE BETWEEN THE OBSERVED ADVERSE EVENTS AND MEDTRONIC PRODUCT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
808249 COREVALVE TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION CRS

Patients

Seq Age Sex Outcome Treatment
1 80 YR Required Intervention